Surveillance of serotypes and antimicrobial susceptibility of Salmonellaspp., Shigella spp. and Vibrio cholerae O1, 1997-1999

Nélida Muñoz, Clara Inés Agudelo, Maria Victoria Ovalle, María Helena Realpe, Edilma Jaramillo, Sandra Núñez, Martha Uzeta, Vianney Portilla, María del Pilar Crespo, María Elena Alvarez, Constanza Sabogal, Mercedes Cano, María Claudia Rodríguez, María Eugenia Peláez, Lesli Bruzón, Mileny Arregocés, Gloria Patricia Londoño, Gloria Inés Dussán, Liliana Patiño, Alix Robinson, .

Keywords: Salmonella spp., Shigella spp., V. cholerae, EDA, serotypes, resistance, surveillance

Abstract

In 1997, a surveillance program to assess the main bacterial pathogens associated with acute diarrheal disease was initiated by the Microbiology Group of the lnstituto Nacional de Salud in collaboration with the Public Health Laboratories (PHL) of the country and PAHO. The program objective was to identify the serotypes and antimicrobial resistance patterns of Salmonella spp., Shigella spp, and Vibrio cholerae 01 isolates. Twenty two PHL participated with a total of 976 isolates from 1997 to 1999; 96% were clinical isolates and 4% were food isolates. 34% were Salmonella spp., 23% Shigella spp., and 42% V. cholerae 01. From Salmonella isolates, 39% were serotype Enteritidis, 27% Typhimurium, 9% group El, 5% Typhi, and 20% other serotypes. Among Shigella isolates, 67% were S. flexneriZa, 30% S. sonnei, 2% S. dysenteriae and 1 % S. boydiiand 99% of the V. cholerae01 isolates were serotype 0gawa.The study on the antimicrobial resistance determined that 56% of the Salmonella isolates were resistant and 22% of them were multiresistant, with the pattern ampicillin, tetracycline and trimethoprim sulfamethoxazole (SXT). 97% of Shigella isolates were resistant and 57% of them were multiresistant, with the pattern to tetracycline, ampicillin, SXT and chloramphenicol. The susceptibility of V. cholerae O1 isolates had not changed during the study period.This study ratifies the importance of surveillance on the epidemiology of these enteropathogens in Colombia. Based on this information it may be possible to treat these diseases and control the spread of antimicrobial bacterial resistance.

Downloads

Download data is not yet available.
  • Nélida Muñoz Grupo de Microbiología, Instituto Nacional de Salud, Bogotá, D.C.
  • Clara Inés Agudelo Grupo de Microbiología, Instituto Nacional de Salud, Bogotá, D.C.
  • Maria Victoria Ovalle Grupo de Microbiología, Instituto Nacional de Salud, Bogotá, D.C.
  • María Helena Realpe Grupo de Microbiología, Instituto Nacional de Salud, Bogotá, D.C.
  • Edilma Jaramillo LSP de Antioquia
  • Sandra Núñez LSP de Bogotá
  • Martha Uzeta Clínica del Niño, Bogotá.
  • Vianney Portilla LSP de Santander
  • María del Pilar Crespo Valle de Liii, Cali
  • María Elena Alvarez LSP de Caldas
  • Constanza Sabogal LSP de Tolima
  • Mercedes Cano LSP de Risaralda
  • María Claudia Rodríguez Hospital Erasmo Meoz. Cúcuta
  • María Eugenia Peláez LSP de Córdoba
  • Lesli Bruzón LSP de La Guajira
  • Mileny Arregocés LSP de Magdalena
  • Gloria Patricia Londoño LSP de Amazonas
  • Gloria Inés Dussán LSP de Huila
  • Liliana Patiño LSP de Nariño
  • Alix Robinson LSP de Arauca
How to Cite
1.
Muñoz N, Agudelo CI, Ovalle MV, Realpe MH, Jaramillo E, Núñez S, et al. Surveillance of serotypes and antimicrobial susceptibility of Salmonellaspp., Shigella spp. and Vibrio cholerae O1, 1997-1999. biomedica [Internet]. 2000 Sep. 1 [cited 2024 May 18];20(3):210-7. Available from: https://revistabiomedica.org/index.php/biomedica/article/view/1062
Published
2000-09-01
Section
Original articles

Altmetric

Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views
QR Code